HomeCNSP • NASDAQ
add
CNS Pharmaceuticals Inc
Previous close
$7.98
Day range
$7.70 - $8.24
Year range
$7.50 - $221.94
Market cap
3.50M USD
Avg Volume
25.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.34M | 22.36% |
Net income | -4.30M | -21.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.34M | -22.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.05M | 1,500.49% |
Total assets | 13.75M | 727.83% |
Total liabilities | 2.78M | -54.38% |
Total equity | 10.97M | — |
Shares outstanding | 455.16K | — |
Price to book | 0.18 | — |
Return on assets | -96.61% | — |
Return on capital | -122.65% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.30M | -21.34% |
Cash from operations | -3.24M | -1.56% |
Cash from investing | — | — |
Cash from financing | 9.83M | 184.17% |
Net change in cash | 6.59M | 2,371.33% |
Free cash flow | -758.50K | 55.73% |
About
Founded
2017
Headquarters
Website
Employees
5
